This study aimed to determine whether serum PCSK9 levels are increased in patients with the rare autoimmune liver diseases AIH, PBC, and PSC, and to assess whether PCSK9 levels are associated with disease severity, fibrosis stage, or sex. This evidence concerns the gene PCSK9 and pancreatic serous cystadenoma.